Opening of potassium channels the common cardioprotective link between preconditioning and natural hibernation?

Circulation

Volumn 99, Issue 23, 1999, Pages 3079-3085

  Kevelaitis, Egidijus ^b   Peynet, Jacqueline ^a   Mouas, Christian ^a   Launay, Jean Marie ^a   Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

Ischemia; Potassium; Receptors; Transplantation

Indexed keywords

ACETYLCHOLINE; CREATINE KINASE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GLIBENCLAMIDE; PAPAVERINE; POTASSIUM CHANNEL; PROSTAGLANDIN F2 ALPHA; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CHANNEL GATING; COLD TOLERANCE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG RECEPTOR BINDING; ENZYME RELEASE; HEART EDEMA; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HEART PROTECTION; HIBERNATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033564063     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.23.3079     Document Type: Article

References (31)

1. De Maria R, Minoli L, Parolini M, Gavazzeni G, Gentile M, Grossi P, Livi U, Parisi F, Utili R. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. J Heart Lung Transplant. 1996;15:124-135.
2. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci. 1994;15:19-25.
3. Perrault LP, Menasché P, Bel A, Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, Moalic J-M. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg. 1996;112: 1378-1386.
4. 1-selective adenosine agonist preconditions rabbit heart. Can J Cardiol. 1996;12:517-521.
5. 1-adrenergic mechanism. Circ Res. 1993;73:656-670.
6. Schultz JEJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 1996;78:1100-1104.
7. Chien GL, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol. 1996;28: 1895-1900.
8. 1-but not μ-or κ-opioid receptors. Circulation. 1998;97:1282-1289.
9. Oeltgen PR, Walsh JW, Hamann SR, Randall DC, Spurrier WA, Myers RD. Hibernation "trigger": opioid-like inhibitory action on brain function of the monkey. Pharmacol Biochem Behav. 1982;17:1271-1274.
10. Oeltgen PR, Nilekani SP, Nuchols PA, Spurrier WA, Su T-P. Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci. 1988;43:1565-1574.
11. Menasché P, Termignon J-L, Pradier F, Grousset C, Mouas C, Alberici G, Weiss M, Piwnica A, Bloch G. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg. 1994;8:207-213.
12. 5]-enkephalin). J Thorac Cardiovasc Surg. 1994;107: 964-967.
13. Boiling SF, Tramontini NL, Kilgore KS, Su T-P, Oeltgen PR, Harlow HH. Use of "natural" hibernation induction triggers for myocardial protection. Ann Thorac Surg. 1997;64:623-627.
14. Fans B, Peynet J, Wassef M, Bel A, Mouas C, Duriez M, Menasché P. Failure of preconditioning to improve postcardioplegia stunning of minimally infarcted hearts. Ann Thorac Surg. 1997;64:1735-1741.
15. Karck M, Rahmanian P, Haverich A. Ischemic preconditioning enhances donor heart preservation. Transplantation. 1996;62:17-22.
16. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81: 1072-1082.
17. + channels by protein kinase C. Circ Res. 1998;83:110-114.
18. ATP channels. Am J Physiol. 1998;274:H909-H914.
19. Boiling SF, Su T-P, Childs KF, Ning X-H, Horton N, Kilgore K, Oeltgen PR. The use of hibernation induction triggers for cardiac transplant preservation. Transplantation. 1997;63:326-329.
20. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta. 1989;987:69-74.
21. 2+ release from an intracellular pool in myocytes and neurons. Circ Res. 1992;70:66-81.
22. + channels. Circ Res. 1996;79:399-406.
23. North RA, Williams JT, Surprenant A, Christie MJ. μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A. 1987;84:5487-5491.
24. +-ATPase activity reduces the infarct size-limiting effect of preconditioning in rabbit hearts. Circulation. 1997;96:599-604.
25. Bauer B, Simkhovich BZ, Kloner RA, Pryklenk K. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury? Circulation. 1993;88:659-672.
26. Shirai T, Rao V, Weisel RD. Preconditioning human cardiomyocytes and endothelial cells. J Thorac Cardiovasc Surg. 1998;115:210-219.
27. Kevelaitis E, Nyborg N, Menasché P. Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage. Transplantation. 1997;64:660-663.
28. Kevelaitis E, Mouas C, Menasché P. Poststorage diastolic abnormalities of heart transplants: is vascular dysfunction or myocardial contracture the culprit? J Heart Lung Transplant. 1996;15:461-469.
29. Raffa R, Martinez RP. The "glibenclamide-shift" of centrally-acting antinociceptive agents in mice. Brain Res. 1995;677:277-282.
30. Menasché P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Preconditioning with potassium channel openers: a new concept for enhancing cardioplegic protection? J Thorac Cardiovasc Surg. 1995;110: 1606-1614.
31. Kersten JR, Schmeling TJ, Hettrick DA, Pagel PS, Gross GJ, Warltier DC. Mechanism of myocardial protection by isoflurane. Anesthesiology. 1996;85:794-807.